Dr. Nakhoda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111Phone+1 215-728-4300
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
University of MarylandResidency, Internal Medicine, 2014 - 2017
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2014
Certifications & Licensure
NJ State Medical License 2022 - 2025
PA State Medical License 2017 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- YIA24-002: Patients' Perspectives on Being Treated by Multiple Care Teams for Autologous Transplant/CAR-T Eligible Lymphoma and Multiple Myeloma.Zachary A K Frosch, Clark Meshack, Caitlin Meeker, Asya Varshavsky-Yanovsky, Rashmi Khanal
Journal of the National Comprehensive Cancer Network. 2024-04-05 - 3 citationsChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyWilliam G Wierda, Jennifer Brown, Jeremy S Abramson, Farrukh Awan, Syed F Bilgrami
Journal of the National Comprehensive Cancer Network. 2024-04-01 - 17 citationsMosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial.Lihua E Budde, Adam J Olszewski, Sarit Assouline, Izidore S Lossos, Catherine Diefenbach
Nature Medicine. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
